Immunotherapy in Advanced Prostate Cancer—Light at the End of the Tunnel?

Immunotherapeutic treatment approaches are now an integral part of the treatment of many solid tumors. However, attempts to integrate immunotherapy into the treatment of prostate cancer have been disappointing so far. This is due to a highly immunosuppressive, “cold” tumor microenvironment, which is...

Descripción completa

Detalles Bibliográficos
Autores principales: von Amsberg, Gunhild, Alsdorf, Winfried, Karagiannis, Panagiotis, Coym, Anja, Kaune, Moritz, Werner, Stefan, Graefen, Markus, Bokemeyer, Carsten, Merkens, Lina, Dyshlovoy, Sergey A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910587/
https://www.ncbi.nlm.nih.gov/pubmed/35269712
http://dx.doi.org/10.3390/ijms23052569

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910587/
https://www.ncbi.nlm.nih.gov/pubmed/35269712
http://dx.doi.org/10.3390/ijms23052569

Ejemplares similares